ABOUT US > OUR GOVERNANCE > BOARD OF DIRECTORS > DR. ALLAN MANDELZYS
BOARD OF DIRECTORS
DR. ALLAN MANDELZYS, PHD, MBA, LIFE SCIENCES ADVISOR & MENTOR AT CEIM (CENTRE D’ENTERPRISE ET D’INNOVATION DE MONTRÉAL)
Dr. Allan Mandelzys is currently a member of the Board of Matrizyme. He is an accomplished biotechnology executive and Board member with more than twenty years of industry experience in both private and publicly-listed companies. For the past five years, Dr. Mandelzys has managed his own life sciences consulting business, assisting company management and venture capital firms to deliver high value to stakeholders. Dr. Mandelzys is also a member of the Board of Clementia Pharmaceuticals, a NASDAQ-listed biotechnology company dedicated to the development and commercialization of treatments for rare bone diseases and Chairman of the Board of Searchlight Pharma, a Canadian specialty pharmaceutical company focused on women’s health. Dr. Mandelzys earned his doctorate in physiology and master of business administration from McGill University. Dr. Mandelzys also holds a Bachelor of Science degree from the University of Toronto and received his post-doctoral training at the Roche Institute of Molecular Biology. Allan joined the Exactis Board of Directors in July 2020.